Overview Fundamentals API Earnings EOD API Sample Code Pricing

Supported exchanges /
SHE /
300204.SHE

Staidson Beijing Biopharma (300204 SHE) stock market data APIs

¥8.02 0.34(4.4%) as of November 22, 2024

Price chart is built with Anychart

Staidson (Beijing) BioPharmaceuticals Co., Ltd. primarily engages in the research and development, production, and marketing of therapeutic drugs in China. The company offers protein drugs, including therapeutic monoclonal antibody drugs; gene therapy/cell therapy drugs; and chemical drugs. It principally offers its products under the fields of nervous system related, infectious, gastrointestinal, urinary system, and autoimmune diseases. Staidson (Beijing) BioPharmaceuticals Co., Ltd. was founded in 2002 and is based in Beijing, China.

Staidson Beijing Biopharma Financial Data Overview

Prev. Close	7.68
Open	8.02
Volume	-
High	8.09
Low	7.65
52 wk Range	5.41-12.39
Market Cap	3 669 M
P/E Ratio
Shares Outstanding	478 M
Revenue	351 M
EPS	-0.0124
Dividends (Yield)
Beta	0.501

Our easy-to-use no-coding solutions help you get the data effortlessly:

Excel Financial Add-In Google Sheets Financial Add-In Python
APIs SDK Windows Downloader

No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.

Prices start at $19.99/month

General: {

Code: '300204',

Type: 'Common Stock',

Name: 'Staidson Beijing Biopharma',

Exchange: 'SHE',

CurrencyCode: 'CNY',

CurrencyName: 'Renminbi',

CurrencySymbol: '¥',

CountryName: 'China',

CountryISO: 'CN',

OpenFigi: NULL,

ISIN: 'CNE100001237',

CIK: NULL,

EmployerIdNumber: '',

FiscalYearEnd: 'December',

IPODate: '2011-04-15',

InternationalDomestic: 'International',

Sector: 'Healthcare',

Industry: 'Biotechnology',

}

Staidson Beijing Biopharma Fundamental Data is available in our Financial Data APIs

Net Revenue 351 M
EBITDA -168 238 272
Earnings Per Share -0.47
Income Statements
Balance Sheets
Cash flows

Fundamental data package from $59.99 See full price

Get sample
of Fundamental API Data

Get Staidson Beijing Biopharma Earnings via APIs

Latest Release 2024-10-25
EPS/Forecast NaN

Calendar package from $19.99 See full price

Get sample
earnings calendar API

Get Staidson Beijing Biopharma End-of-day Data via APIs

End of Day, Intraday and Live APIs
Splits
Dividends

All world package from $19.99 See full price

Get sample
of End-of-Day API Data

Get Staidson Beijing Biopharma latest news via APIs

InflaRx Announces Amendment of Co-Development Agreement and Additional Equity Investment by Staidson in Connection with Regulatory Filing in China for Anti-C5a-Antibody for Treatment of COVID-19

1 year ago

InflaRx N.V. InflaRx will provide access to certain clinical, manufacturing and regulatory documentation for vilobelimab to facilitate STS’s regulatory filings in China STS plans to request regulat...

BIOPHARMACEUTICAL COMPANY
CHINA
COMPANY
DEVELOPMENT
INFLAMMATORY DISEASES
INFLARX
INVESTMENT COMPANY
ORDINARY SHARES
REGULATORY APPROVAL
SHARE PURCHASE AGREEMENT

News API is available at any package from $19.99 See full price

Get sample of News API

Robust, powerful and easy to use

Our advantages

Prices start at
$19.99

Fast+ support 24/7 via web-chat and email

Robust, powerful and reliable data

One click API for all financial data you need

Sample code for your quick start

Ready-to-go solutions

Our easy-to-use no-coding solutions help you get the data directly to MS Excel and Google Sheets. Or download the CSV (TXT) files effortlessly with tools for Windows and Linux.

Excel Financial Add-In Google Sheets Financial Add-In Python
APIs SDK Windows Downloader

Best price for all data API

Prices start at $19.99/month

All-In-One

$99.99/per month

100 000+ API requests per day
EOD Data - All World Extended
Splits and Dividends
Fundamental Data
Bonds Data
Options Data
1000+ currency pairs
1000+ cryptocurrency pairs

Do you have any questions?

support@eodhistoricaldata.com